FIGO World Congress 2021 Blog – Day Two
A cross-specialty keynote
Prof. Beverley Vollenhoven’s keynote lecture on “Maternal Fetal Medicine and Reproductive Medicine – Crosstalk Between Subspecialties” highlighted the importance of communications between Reproductive Endocrinology and Infertility (REI) specialists and specialists in maternal and fetal medicine (MFM) to maintain a positive working relationship between the two subspecialties.
Professor Vollenhoven took advantage of this conference to highlight how the behavior of REI specialists towards infertile women can help improve their pregnancy and postpartum outcomes. This is why, she explained, “IER specialists should not behave as if what they are doing does not matter during pregnancy.”
Cancer and hormones
Later, the FIGO Gynecological Oncology Branch organized a session chaired by Dr Alon Altman on ‘Cancer and Hormones’, with comments from Dr Andreas Obermair, Dr David Gershenson, Dr Debra Evaniuk and Dr Helen MacKay.
Dr Obermair focused on the effectiveness of hormone therapy for endometrial hyperplasia with atypia (EHA) and endometrial adenocarcinoma (EAC) in vulnerable women, while Dr Gershenson presented the endocrine management of low-grade serous ovarian cancer and sex cord stromal tumors.
Dr Evanuik’s presentation explored the risks and relationships between hormone therapy use and breast cancer in key populations, and Dr MacKay addressed key questions regarding the use of hormone therapy in treatment. gynecological cancers.
Fetal growth: best practices and game changers
At the same time, the Maternal and Fetal Health component of FIGO organized a session on the FIGO Fetal Growth Initiative, with Dr Gerad Visser, Dr Apostolos Athanasiadis, Dr Nir Melamed and Dr Federico Mecacci.
Dr Athanasiadis presented the prediction and prevention of fetal growth restriction (FGR) in lower and upper middle income countries, particularly highlighting medical comorbidities, biomarkers and ultrasound markers as key elements in the prediction of FGR. Dr Visser focused on the use of maps and Dopplers in predicting FGR, offering recommendations based on regional differences.
Federico Mecacci gave a talk on ‘game changers’ that could advance existing clinical practice, highlighting new technologies and tools that can help differentiate RGF and small-for-gestational-age (SGA) fetuses . Dr Melamed closed the session with a lecture on the most recent FIGO Good Practice Advice on Fetal Growth Restriction, focused on providing a practical guide to the prediction, prevention and management of FGR.
Ending gender-based violence
This was followed by various sessions, including one on “Gender-based violence: what does it take for a new world order? »Set up by the FIGO Committee for Human Rights, Refugees and Violence Against Women.
Professor Kristina Gemzell Danielsson began the session by emphasizing that the COVID-19 pandemic represents a window of opportunity to advance sexual and reproductive health and rights. Dr Claudia Garcia-Moreno followed with a lecture presenting the RESPECT framework as a tool for the prevention of gender-based violence (GBV).
Dr Hemantha Senanayaka discussed steps to change the status of women, focusing on the main findings of the first UNFPA body autonomy report. Professor Chiara Benedetto focused on interventions for women in crisis situations, highlighting the particular vulnerability of women in humanitarian situations, including refugees.
Dr Diana Galimberti explored how legislative changes to tackle GBV must be accompanied by cultural changes. Professor Shantha Kumari ended the panel by highlighting the importance of advocacy and partnerships between international organizations, governments and civil society as key avenues to prevent GBV.
We finally reached Australia and New Zealand
We ended the day with the Australia and New Zealand Virtual Regional Evening, hosted by the Royal Australian and New Zealand College of Obstetricians and Gynecologists (RANZCOG). The evening focused on the health of Indigenous women, and we heard from speakers on various issues affecting Indigenous women around the world, such as HPV and cervical testing, the impact of residential schools. Indian and racism on health, and maternal mortality in various countries such as New Zealand. , Australia, Papua New Guinea, Canada, United States and Mexico.
It was an engaging and worthy end to the first full day of World Congress content. Recordings of the entire session will be available to watch on demand on the Virtual congress platform Within 24 hours.
To learn more about the Congress or to register, visitwww.figo2021.org.